Bone marrow stem cells injected into eyes in bold blindness trial
NCT ID NCT01736059
First seen Jan 31, 2026 · Last updated Apr 28, 2026 · Updated 7 times
Summary
This early-stage study tests whether it is safe to take a person's own bone marrow stem cells and inject them into the eye to treat blindness caused by diseases like macular degeneration and diabetic retinopathy. Fifteen adults with severe vision loss will receive the injection and be monitored for side effects. The goal is to see if the procedure is feasible and safe, not yet to prove it restores sight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California Davis
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.